MDAngle

• Experiencing the Evolution of Early NSCLC Treatment   Jared Weiss, MD, reflects on his first encounter in training with a patient with early NSCLC and how the treatment landscape has rapidly changed since then.
  Medscape, January 08, 2024
• Early NSCLC: Three Forms That Contribute to Failure to Diagnose   Jared Weiss, MD, reflects on the profound impact of patient experiences in which early diagnosis of NSCLC was missed.
  Medscape, January 08, 2024
• Changes in the Treatment Landscape of Early-Stage Non-Small Cell Lung Cancer   Narjust Florez, MD, reflects on the significant changes in the treatment landscape of early-stage non-small cell lung cancer in recent years.
  Medscape, January 04, 2024
• ASH 2023: New Geriatric Assessment Tools in DLBCL   Dr Suchitra Sundaram discusses the applicability of assessment tools to help reduce toxicities in the treatment of non-Hodgkin lymphoma.
  Medscape, December 29, 2023
• The Clinical Implications of Findings From SABCS 2023   Dr Tarah J. Ballinger explores the impact of the INAVO120 study and the NATALEE trial on HR+/HER2- metastatic breast cancer.
  Medscape, December 27, 2023
• ASH 2023: Key Insights on Advances in DLBCL   Dr Suchitra Sundaram highlights some of the practice-changing data presented at ASH 2023.
  Medscape, December 15, 2023
• SABCS 2023: Highlights in HR+/HER2- Breast Cancer   Tarah J. Ballinger, MD, provides her biggest takeaways from SABCS 2023 in HR+/HER2- breast cancer.
  Medscape, December 13, 2023
• ASH 2023: Anticipating Impactful Data in DLBCL   Dr Suchitra Sundaram highlights key studies to be presented at ASH 2023.
  Medscape, December 01, 2023
• IKCS 2023: New Data in Metastatic Kidney Cancer   Dr Katy Beckermann reviews new and encouraging data presented at IKCS 2023.
  Medscape, November 29, 2023
• AAO 2023: Clinical Insights From New Data on AMD   Dr Vaidehi Dedania reflects on the impact of AAO 2023 on her patients with age-related macular degeneration.
  Medscape, November 27, 2023
• SABCS 2023: Anticipating New Data in HR+/HER2- Breast Cancer   Tarah J. Ballinger, MD, awaits new updates in HR+/HER2- breast cancer.
  Medscape, November 27, 2023
• AAO 2023: Improving Patients' QOL in Diabetic Macular Edema   Dr Sunir Garg reflects on how highlights from AAO 2023 will affect his patients with diabetic macular edema.
  Medscape, November 20, 2023
• IKCS 2023: New Advances in Metastatic Kidney Cancer   Dr Katy Beckermann highlights a new tyrosine kinase inhibitor and the unique collaborative discussions shaping the future of kidney cancer care, as reported at IKCS 2023.
  Medscape, November 15, 2023
• ESMO 2023: The Impact of New Data on Patient Care   Rana R. McKay, MD, examines new data and AI technology in prostate cancer care at ESMO 2023.
  Medscape, November 13, 2023
• ESMO 2023: Reflecting on New Data in Advanced NSCLC   Julia Rotow, MD, analyzes the latest research presented at ESMO that could impact patient care going forward.
  Medscape, November 13, 2023
• AAO 2023: New Positive Data for Wet AMD   Dr Vaidehi Dedania reviews interesting data presented at AAO 2023 and discusses what's next for age-related macular degeneration.
  Medscape, November 10, 2023
• AAO 2023: Advances in Diabetic Macular Edema Treatment and a Focus on Representation in Clinical Trials   Dr Sunir Garg shares highlights from AAO 2023, including new data on recently approved treatments for diabetic macular edema and papers that addressed racial and ethnic underrepresentation in clinical trials.
  Medscape, November 09, 2023
• IKCS 2023: Anticipating Data Across All of Kidney Cancer   Katy Beckermann, MD, PhD, previews the upcoming IKCS meeting in Nashville, Tennessee.
  Medscape, November 02, 2023
• ESMO 2023: Advancing Prostate Cancer Care   Dr Rana R. McKay offered insights on the practice-changing data presented at ESMO 2023.
  Medscape, October 27, 2023
• ESMO 2023: Key Highlights in Advanced NSCLC   Dr Julia K. Rotow examined the latest breakthroughs in advanced NSCLC as presented at ESMO 2023.
  Medscape, October 27, 2023